Prot# ACH443-015: A Phase II, Randomized, Blinded, 12-Wk Comparison of Elvucitabine in Combination w/Efavirenz & Tenofovir v. Lamivudine in Combination w/Efavirenz & Tenofovir in HIV-1-Infected, Treatment-Naïve Subjects, w/A 12-Wk Extension

Project: Research project

Project Details

StatusFinished
Effective start/end date4/17/06 → 8/8/07

Funding

  • PPD Development (ACH443-015)
  • Achillion Pharmaceuticals, Inc. (ACH443-015)